Dupilumab: an Additional Arrow in the Quiver for Prurigo Nodularis? Data From a Real-Life Setting
Our findings reflect the real-world practice of treating PN and support the use of dupilumab as a new effective treatment option, with significant improvements in pruritus, quality of life, and disease severity compared to antidepressant therapy, suggesting its potential as a preferred therapeutic option for PN.
Authors
- Aleksandra Stefaniak (ORCID: https://orcid.org/0000-0002-3714-8434)
- Eugenia Veronica Di Brizzi (ORCID: https://orcid.org/0000-0002-0278-2443)
- Anna Balato (ORCID: https://orcid.org/0000-0001-5485-0172)
- Stefano Caccavale (ORCID: https://orcid.org/0000-0001-7433-9283)
- Caterina M. Giorgio
- Giuseppe Argenziano (ORCID: https://orcid.org/0000-0003-1413-8214)
- Roberta Di Caprio (ORCID: https://orcid.org/0000-0002-0487-1327)
Institutions
- University of Campania "Luigi Vanvitelli" (IT)
Publication Details
- Journal
- Dermatology Practical & Conceptual
- Published
- 2025-10-31
- DOI
- https://doi.org/10.5826/dpc.1504a5639
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00